Genaera (GENR) CEO Buys 30K Shares
Genaera Corp. (Nasdaq: GENR) Chairman/CEO, John Armstrong, bought 30,000 shares from 12/20-12/21 at prices from $1.73-$2.09, bringing his holding sto 68,334 shares.
Genaera Corporation, a biopharmaceutical company, engages in the research and development of pharmaceuticals with focus on obesity, anti-angiogenesis, and respiratory diseases.
Genaera Corporation, a biopharmaceutical company, engages in the research and development of pharmaceuticals with focus on obesity, anti-angiogenesis, and respiratory diseases.
You May Also Be Interested In
- Faber - Greek Exit Good for Markets, India and China a Risk
- W&T Offshore (WTI) CEO Buys 50K Shares
- Best Buy (BBY) CEO Mikan Buys 100K Shares
Create E-mail Alert Related Categories
Insider TradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
